Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Cash Flow Quality Index
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Cash Flow Quality Index of 17.35x as of September 2025. Operating cash flow of CN¥90.75 Million exceeds net income of CN¥5.23 Million, indicating high earnings quality where cash backs reported profits. Explore Luoxin Pharmaceuticals Group Stock Co Lt strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Luoxin Pharmaceuticals Group Stock Co Ltd Cash Flow Quality Index (2011–2021)
Historical Cash Flow Quality Index for Luoxin Pharmaceuticals Group Stock Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Luoxin Pharmaceuticals Group Stock Co Lt to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2021)
Year-by-year earnings quality comparison for Luoxin Pharmaceuticals Group Stock Co Ltd. For live market cap and the full company financial profile, see 002793 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.29x | CN¥120.63 Million | CN¥421.65 Million | ▲ +402.5% |
| 2020 | -0.09x | CN¥-32.40 Million | CN¥342.60 Million | ▼ -153.1% |
| 2019 | 0.18x | CN¥116.33 Million | CN¥653.76 Million | ▼ -82.6% |
| 2018 | 1.02x | CN¥114.12 Million | CN¥111.35 Million | ▲ +16.1% |
| 2017 | 0.88x | CN¥102.27 Million | CN¥115.85 Million | ▲ +21.8% |
| 2016 | 0.72x | CN¥72.74 Million | CN¥100.36 Million | ▲ +2.0% |
| 2015 | 0.71x | CN¥58.12 Million | CN¥81.79 Million | ▲ +8.7% |
| 2014 | 0.65x | CN¥41.83 Million | CN¥63.96 Million | ▼ -53.6% |
| 2013 | 1.41x | CN¥64.75 Million | CN¥45.96 Million | ▲ +126.9% |
| 2012 | 0.62x | CN¥33.31 Million | CN¥53.67 Million | ▼ -56.6% |
| 2011 | 1.43x | CN¥46.53 Million | CN¥32.52 Million | — |